Literature DB >> 32770031

A quality improvement project improving the value of iNO utilization in preterm and term infants.

Hannah Fischer1, Tamina Singh2, Lori Devlin2, Olugbemisola Obi2, Tonya Robinson2, Seth Schultz2, Sucheta Telang2, Scott Duncan2.   

Abstract

OBJECTIVE: Inhaled NO (iNO) is used in the NICU for management of hypoxemic respiratory failure. The cost of iNO is significant and does not consistently improve outcomes in infants <34 weeks. PROJECT
DESIGN: Our team used The Model for Improvement to design a quality improvement project to utilize iNO for appropriate indications, ensure response to therapy and initiate timely weaning. The project was carried out at a Level IV NICU and successful interventions spread to a smaller Level III NICU.
RESULTS: This project demonstrated significant improvement in all measures; total iNO hours per month, average iNO hours per patient, and the percentage of prolonged iNO courses. With an estimated cost of $115/h, the cost per patient for iNO use declined by half from $21,620 to $10,580.
CONCLUSIONS: Our team improved the value of iNO utilization at our institution and spread successful interventions to another NICU in our network.

Entities:  

Year:  2020        PMID: 32770031     DOI: 10.1038/s41372-020-0768-0

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  3 in total

Review 1.  NIH consensus development conference: Inhaled nitric oxide therapy for premature infants.

Authors:  F Sessions Cole; Claudia Alleyne; John D E Barks; Robert J Boyle; John L Carroll; Deborah Dokken; William H Edwards; Michael Georgieff; Katherine Gregory; Michael V Johnston; Michael Kramer; Christine Mitchell; Josef Neu; DeWayne M Pursley; Walter Robinson; David H Rowitch
Journal:  NIH Consens State Sci Statements       Date:  2010-10-29

Review 2.  Nitric oxide for respiratory failure in infants born at or near term.

Authors:  Keith J Barrington; Neil Finer; Thomas Pennaforte; Gabriel Altit
Journal:  Cochrane Database Syst Rev       Date:  2017-01-05

Review 3.  Inhaled nitric oxide for respiratory failure in preterm infants.

Authors:  Keith J Barrington; Neil Finer; Thomas Pennaforte
Journal:  Cochrane Database Syst Rev       Date:  2017-01-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.